Archive for October, 2003

Who's Going To Pay For Global Health?

Who’s Going To Pay For Global Health? The amazingly swift global response to the SARS outbreak earlier this year demonstrated once and for all that it is possible for countries to join forces and fight epidemics quickly and effectively. So, shouldn’t the same apply to the true pandemics � AIDS, malaria and tuberculosis? Indeed it […]


Click here for reuse options!
Copyright 2003 Biotechblog

Who’s Going To Pay For Global Health?

Who’s Going To Pay For Global Health? The amazingly swift global response to the SARS outbreak earlier this year demonstrated once and for all that it is possible for countries to join forces and fight epidemics quickly and effectively. So, shouldn’t the same apply to the true pandemics � AIDS, malaria and tuberculosis? Indeed it […]


Click here for reuse options!
Copyright 2003 Biotechblog

Seeking a Prescription for Biogenerics

Seeking a Prescription for Biogenerics No U.S. laws allow for generic versions of off-patent biotech medicines. Several forces are now working to change that


Click here for reuse options!
Copyright 2003 Biotechblog

Why Merck Missed the Mark

Why Merck Missed the Mark S&P’s Herman Saftlas talks about the Street’s reaction to the drug giant’s disappointing earnings report and what the future may hold


Click here for reuse options!
Copyright 2003 Biotechblog

%d bloggers like this: